Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 20(31-32): 3629-31, 2002 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-12399187

RESUMO

Vaccines are needed to reduce the zoonotic reservoir of Schistosoma japonicum infection in bovines in China. We have developed two experimental DNA vaccines and have already shown these to be capable of inducing partial protection in water buffalo naturally exposed to the risk of S. japonicum infection in the field. We now report a similar field trial in cattle, the other major bovine reservoir host species in China. Groups of cattle were vaccinated with the VRSj28 vaccine or the VRSj23 vaccine, or, to test whether protection could be enhanced by combination vaccination, with both these DNA vaccines together. After vaccination, the cattle were exposed to natural infection in the field for a period of 54 days. Worm and egg counts carried out at the end of the experiment showed that each of the vaccine groups showed partial resistance, and that combined vaccination was not more effective than vaccination with the individual plasmids.


Assuntos
Doenças dos Bovinos/prevenção & controle , Schistosoma japonicum/imunologia , Esquistossomose Japônica/prevenção & controle , Esquistossomose Japônica/veterinária , Vacinas de DNA/uso terapêutico , Animais , Anticorpos Anti-Helmínticos/biossíntese , Búfalos/parasitologia , Bovinos , Doenças dos Bovinos/diagnóstico , Doenças dos Bovinos/parasitologia , China , Feminino , Esquemas de Imunização , Masculino , Contagem de Ovos de Parasitas/métodos , Contagem de Ovos de Parasitas/estatística & dados numéricos , Schistosoma japonicum/isolamento & purificação , Esquistossomose Japônica/diagnóstico , Vacinas Combinadas/uso terapêutico , Vacinas Sintéticas/uso terapêutico
2.
Artigo em Inglês | MEDLINE | ID: mdl-12168013

RESUMO

Triose-phosphate isomerase is an important candidate for schistosoma antigens. An 800 bp DNA fragment was amplified by RT-PCR from adult Schistosoma japonicum mRNA. Sequence analysis revealed that this fragment contained S. japonicum (Chinese strain) triose-phosphate isomerase gene. Then this gene was cloned into the expression vector pGEX-4T and subsequently expressed in E. coli. The recombinant GST-fusion protein was purified by glutathione agarose affinity chromatography. Its molecular weight was determined to be 54 kD. The yield of expression was around 30 mg/L E. coli culture. Western blotting showed that the recombinant protein had good antigenicity which could be helpful for the making of anti-S. japonicum multi-valent recombinant vaccine.

3.
Artigo em Inglês | MEDLINE | ID: mdl-12174284

RESUMO

A 600 bp DNA fragment was amplified by PCR, from an adult Schistosoma japonicum cDNA library. Sequence analysis revealed that this fragment containedthe S. japonicum Chinese Mainland strain fatty acid binding protein (Sj-14FABPc) gene. This gene was then cloned into the expression vector pGEX-2T, and subsequently expressed in Escherichia coli. The recombinant GST-fusion protein could be purified by glutathione agarose affinity chromatography. Its molecular weight was about 41 kD. The yield of expression was around 25 mg/L E. coli culture. The immunological test suggested that the recombinant protein had good antigenicity, and could be developed into a new vaccine molecule of S. japonicum.

4.
Artigo em Inglês | MEDLINE | ID: mdl-12219234

RESUMO

The gene of the 28 kD glutathione S-transferase (GST) from the Chinese strain of Schistosoma japonicum had been expressed in the silkworm (Bombyx mori) cells and larvae by Bombyx mori nuclear polyhedrosis virus (BmNPV) vector which had been modified. The GST gene was inserted into the right position of the BmNPV genome as identified by Southern hybridization. The product was a 28 kD protein, had GST activity and antigenicity. The yield in BmN cells (1x10(6) cells/ml) was 0.77 mg and more than 5 mg in a silkworm larvae. All the results showed that it is possible to develop the GST expressed in the silkworm larvae to a new kind of genetic engineered schistosomiasis vaccine.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...